High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2581-2585

  Akkina, Ramesh K ^a   Walton, Raquel M ^a   Chen, Meng Liang ^b   Li, Qi Xiang ^b   Planelles, Vicente ^b   Chen, Irvin S Y ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE;

EID: 0029872245     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2581-2585.1996     Document Type: Article

References (33)

1. Akkina, R. K., J. D. Rosenblatt, A. G. Campbell, I. S. Y. Chen, and J. A. Zack. 1994. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84:1393-1398.
2. Bahner, I., C. Zhou, X.-J. Yu, Q.-L. Hao, J. C. Guatelli. and D. B. Kohn. 1993. Comparison of trans-dominant inhibitory human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J. Virol. 67:3199-3207.
3. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J.-K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to a very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037
4. Camerini, D., V. Planelles, and I. S. Y. Chen. 1994. CD26 antigen and HIV fusion? Science 264:1160-1161.
5. Cassel, A., M. Cottler-Fox, S. Doren, and C. E. Dunbar. 1993. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp. Hematol. 21:585-591.
6. Civin, C. I., and S. D. Gore. 1993. Antigenic analysis of hematopoiesis: a review. J. Hematother. 2:137-144
7. Davis, B. R., D. H. Schwartz, J. C. Marx, C. E. Johnson, J. M. Berry, J. Lyding, T. C. Merigan, and A. Zander. 1991. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J. Virol. 65:1985-1990.
8. + progenitor cells are not infected by HIV-1 but show impaired clonogenesis. Br. J. Haematol. 85:20-24.
9. Dougherty, J. P., R. Wisniewski, S. L. Yang, B. W. Rhode, and H. W. Temin. 1989. New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J. Virol. 63:3209-3212.
10. Folks, T. M. 1991. Human immunodeficiency virus in bone marrow, still more questions than answers. Blood 77:1625-1626.
11. Fraser, C., C. J. Eaves, S. J. Szilvassy, and R. K. Humphries. 1990. Expansion in vitro of retrovirally marked totipotent hematopoietic stem cells. Blood 76:1071-1076.
12. Hock, R. A., and A. D. Miller. 1986. Retrovirus-mediated transfer and expression of drug resistance genes in human hematopoietic progenitor cells. Nature (London) 320:275-277.
13. Hughes, P. F. D., C. J. Eaves, S. J. Szilvassy, and R. K. Humphries. 1989. High efficiency gene transfer to human hematopoietic cells maintained in long-term marrow culture Blood 74:1915-1922.
14. Hughes, P. F. D., J. D. Thacker, D. Hogge, H. J. Sutherland, T. E. Thomas, P. M. Langdorp, C. J. Eaves, and R. K. Humphries. 1992. Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures. J Clin. Invest. 89:1817-1824.
15. Liem, D. R., A. Ramezani, X. Li, and S. Joshi. 1993. The development of retroviral vectors expressing trans-dominant mutants of HTV-1 proteins to confer anti-HIV resistance. Hum. Gene Ther. 4:625-634.
16. Lin, S., N. Gaiano, P. Culp, J. C. Burns, T. Friedmann, J.-K. Yee, and N. Hopkins. 1994. Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. Science 265:666-669
17. Mastromarino, P., C. Conti, P. Goldoni, B. Hauttecoeur, and N. Orsi. 1987. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J. Gen Virol. 68:2359-2369.
18. Miller, A. D. 1992. Human gene therapy comes of age. Nature (London) 257:455-460.
19. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
20. Moore, K. A., A. B. Deisseroth, C. L. Reading, D. E. Williams, and J. W. Belmont. 1992. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture initiating cells Blood 79:1393-1399
21. Morgan, R. A., and W. F. Anderson. 1993. Human gene therapy. Annu. Rev. Biochem. 62:191-217.
22. Mulligan, R. C. 1993. The science of gene therapy. Science 260:926-932.
23. Nolta, J. A., and D. B. Kohn. 1990. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells Hum. Gene Ther. 1:257-268.
24. Ojwang, J. O., A. Hampel, D. J. Looney, F. Wong-Staal, and J. Rappaport. 1992 Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc. Natl. Acad Sci USA 89:10802-10806
25. Planelles, V., F. Bachelerie, J. B. M. Jowett, A. Haislip, Y. Xie, P. Banooni, T. Masuda, and I. S. Y. Chen. 1995 The fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr. J Virol 69:5883-5889.
26. Sarver, N., E. M. Cantin, P. S. Chang, J. A. Zaia, P. A. Ladne, D. A. Stephens, and J. J. Rossi. 1990. Ribozymes as potential anti-HIV therapeutic agents. Science 247:1222-1225.
27. Scadden, D. T., L. I. Zon, and J. E. Groupman. 1989. Pathophysiology and management of HIV-associated hematologic disorders. Blood 74:1455-1463.
28. Spector, D. H., E. Wade, D. A. Wright, V. Koval, C. Clark, D. Joquish, and S. A. Specter. 1990. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64:2298-2308.
29. Stanley, S. K., S. W. Kessler, J. S. Justement, S. M. Shnittman, J. J. Greenhouse, C. C. Brown, L. Musongela, K. Musey, B. Kapita, and A. S. Fauci. 1992 CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J. Immunol. 149:689-697.
30. + T lymphocytes by retroviral vectors expressing anti-HIV genes. J. Virol. 69:4045-4052.
31. Yee, J.-K., A. Miyanohara, P. LaPorte, K. Bouic, J. C. Burns, and T. Friedmann. 1994. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91:9564-9568.
32. Zack, J. A., S. J. Arrigo, S. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
33. Zhu, Z., S. S. L. Chen, and A. S. Huang. 1990 Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J. Acquired Immune Defic. Syndr. 3:215-219.